FDA inspection
SCA Pharmaceuticals, LLC: FDA inspection ending Oct 20, 2023
FDA inspection 1221018 · Official Action Indicated (OAI) · Windsor, CT
Key facts
| Inspection ID | 1221018 |
|---|---|
| Firm | SCA Pharmaceuticals, LLC |
| FEI number | 3013736415 |
| Address | 755 Rainbow Rd Ste B |
| City | Windsor |
| State | CT |
| ZIP | 06095 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Oct 20, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data